Lee, D. H., Zanwar, S., Dima, D., Goel, U., Chao, A., Lien, K., Banerjee, R., Mazzoni, S., Khouri, J., Williams, L., Anwer, F., Lin, Y., Cassano, R., Addison, D., Cheng, R., Davis, J., Dominick, A., Green, K., Julian, K., Sborov, D., Shetty, S., Vazquez-Martinez, M., Avila, G. D., Dixon, A., Blue, B., Freeman, C. L., Ali, H. M., Locke, F., Alomar, M., Alsina, M., Baz, R., Shain, K., Puglianini, O. A. C., Hansen, D., Grajales-Cruz, A., Raza, S. (2025). Major adverse cardiovascular events after teclistamab in relapsed refractory multiple myeloma: A multicenter study from the u.s. multiple myeloma immunotherapy consortium.. Blood. https://doi.org/10.1182/blood-2025-4066